Browsing by Author "Posada L."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Metadata only Author Correction: Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries (Nature Medicine, (2025), 10.1038/s41591-024-03345-4)(2025-01-01) Lara-Castor L.; O’Hearn M.; Cudhea F.; Miller V.; Shi P.; Zhang J.; Sharib J.R.; Cash S.B.; Barquera S.; Micha R.; Mozaffarian D.; Hakeem R.; Mirzaei M.; Nikiema L.; Manary M.; Geleijnse J.M.; Balfour D.; Mitchell C.; Elmadfa I.; Meyer A.; Zello G.; Ersino G.; Henry C.; Fisberg R.; Skeaff S.; Ng S.W.; Adair L.; Jimenez E.Y.; Zugravu C.A.; Moy F.M.; Serra-Majem L.; Gunnarsdottir I.; Thorsdottir I.; Steingrimsdottir L.; Stuetz W.; Eleraky L.; Freese R.; Erkkola M.; Korkalo L.; Haque A.; Krebs N.F.; Hambidge K.M.; Long J.M.; Jayawardena R.; Waidyatilaka I.; Nöthlings U.; Alexy U.; Strand T.; Sharma S.; Pakseresht M.; Abbott P.; Poh B.K.; Manan W.; Jan Bin Jan Mohamed H.; Shariff Z.M.; Shamsuddin K.; Preston A.M.; Ochoa A.; Posada L.; Oleas M.; Aguero S.D.; Marques L.L.; Mwanza S.; Chileshe J.; Anderson S.G.; Mwaniki E.; Abumweis S.; Noshad S.; Esteghamati A.; Zohoori F.V.; Karupaiah T.; Vaask S.; Dastgiri S.; Moraeus L.; Sipinen J.P.; Lemming E.W.; Lindroos A.K.; Garriguet D.; Swaminathan S.; Kuriyan R.; Kim C.I.; Ridder K.D.; Naska A.; Fernandez A.; Chiplonkar S.; Salanave B.; Hoffman D.; Wieler L.; Mensink G.; Richter A.; Mirmiran P.; Tedla B.; Tayyem R.; Janská V.; Al-Hamad N.; Suarez-Ortegon M.F.; Henjum S.; Kruger H.; Ding E.L.; Eldridge A.; Lara-Castor L.; Mahidol UniversityCorrection to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03345-4, published online 6 January 2025. In the version of the article initially published, in the eighth paragraph of the Discussion, the text “Among large nations, the largest increases in SSB-related T2D burdens were in Mexico, Thailand and the United Kingdom, and in CVD burdens, Colombia, Nigeria, Thailand and Russia. These changes align with rises in SSB consumption in these nations12. Similarly, declining SSB-related cardiometabolic burdens in Brazil, the United States and the United Kingdom (for CVD) are consistent with their decreasing SSB consumption from 1990 to 202012” was incorrect and has now been updated to “Among largely populated nations, the largest increases in SSB-related T2D incidence was in Colombia, USA and Argentina; and in CVD incidence, Nigeria, Russia, Colombia and Thailand. These changes generally align with rises in SSB consumption in these nations, except in the US where slight declines in SSB consumption were offset by increased burdens of diabetes 12. Similarly, declining SSB-related cardiometabolic burdens in Turkey, Brazil, and the United States and the United Kingdom for CVD are consistent with their decreasing SSB consumption from 1990 to 202012.” Additionally, Supplementary Data 1 and 2 have been updated to remove decimals in values greater than 100. These corrections have been made to the HTML and PDF versions of the article.Item Metadata only Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries(2025-01-01) Lara-Castor L.; O’Hearn M.; Cudhea F.; Miller V.; Shi P.; Zhang J.; Sharib J.R.; Cash S.B.; Barquera S.; Micha R.; Mozaffarian D.; Hakeem R.; Mirzaei M.; Nikiema L.; Manary M.; Geleijnse J.M.; Balfour D.; Mitchell C.; Elmadfa I.; Meyer A.; Zello G.; Ersino G.; Henry C.; Fisberg R.; Skeaff S.; Ng S.W.; Adair L.; Jimenez E.Y.; Zugravu C.A.; Moy F.M.; Serra-Majem L.; Gunnarsdottir I.; Thorsdottir I.; Steingrimsdottir L.; Stuetz W.; Eleraky L.; Freese R.; Erkkola M.; Korkalo L.; Haque A.; Krebs N.F.; Hambidge K.M.; Long J.M.; Jayawardena R.; Waidyatilaka I.; Nöthlings U.; Alexy U.; Strand T.; Sharma S.; Pakseresht M.; Abbott P.; Poh B.K.; Manan W.; Jan Bin Jan Mohamed H.; Shariff Z.M.; Shamsuddin K.; Preston A.M.; Ochoa A.; Posada L.; Oleas M.; Aguero S.D.; Marques L.L.; Mwanza S.; Chileshe J.; Anderson S.G.; Mwaniki E.; Abumweis S.; Noshad S.; Esteghamati A.; Zohoori F.V.; Karupaiah T.; Vaask S.; Dastgiri S.; Moraeus L.; Sipinen J.P.; Lemming E.W.; Lindroos A.K.; Garriguet D.; Swaminathan S.; Kuriyan R.; Kim C.I.; Ridder K.D.; Naska A.; Fernandez A.; Chiplonkar S.; Salanave B.; Hoffman D.; Wieler L.; Mensink G.; Richter A.; Mirmiran P.; Tedla B.; Tayyem R.; Janská V.; Al-Hamad N.; Suarez-Ortegon M.F.; Henjum S.; Kruger H.; Ding E.L.; Eldridge A.; Lara-Castor L.; Mahidol UniversityThe consumption of sugar-sweetened beverages (SSBs) is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). However, an updated and comprehensive assessment of the global burden attributable to SSBs remains scarce. Here we estimated SSB-attributable T2D and CVD burdens across 184 countries in 1990 and 2020 globally, regionally and nationally, incorporating data from the Global Dietary Database, jointly stratified by age, sex, educational attainment and urbanicity. In 2020, 2.2 million (95% uncertainty interval 2.0–2.3) new T2D cases and 1.2 million (95% uncertainty interval 1.1–1.3) new CVD cases were attributable to SSBs worldwide, representing 9.8% and 3.1%, respectively, of all incident cases. Globally, proportional SSB-attributable burdens were higher among men versus women, younger versus older adults, higher- versus lower-educated adults, and adults in urban versus rural areas. By world region, the highest SSB-attributable percentage burdens were in Latin America and the Caribbean (T2D: 24.4%; CVD: 11.3%) and sub-Saharan Africa (T2D: 21.5%; CVD: 10.5%). From 1990 to 2020, the largest proportional increases in SSB-attributable incident T2D and CVD cases were in sub-Saharan Africa (+8.8% and +4.4%, respectively). Our study highlights the countries and subpopulations most affected by cardiometabolic disease associated with SSB consumption, assisting in shaping effective policies and interventions to reduce these burdens globally.